| Particulars |
| Company Name |
Aurobindo Pharma Ltd |
| Face Value |
1 |
| BSE Code |
524804 |
| Year End |
202503 |
| Full Year |
| Equity (Rs . Cr) |
58.08 |
| B.V. (Rs) |
369.20 |
| Sales (Rs . Cr) |
10,933.30 |
| NP (Rs . Cr) |
1,741.31 |
| NP Var% |
-11.00 |
| Div% |
0.00 |
| CPS (Rs) |
35.10 |
| EPS (Rs) |
30.00 |
| Traded Value(Rs . Lakhs) |
706.39 |
| 52 Week High |
1,359.00 |
| 52 Week Low |
994.00 |
| Price BSE |
1,336.00 |
| Price NSE |
1,334.00 |
| Market Capital(Rs . Cr) |
77,592.19 |
| P/C Ratio |
38.10 |
| P/E Ratio |
44.60 |
| Price Vs.BV |
3.62 |
| Latest Quarter |
| Year End |
202512 |
| Sales (Rs . Cr) |
2,726.38 |
| NP (Rs . Cr) |
594.94 |
| NP Var % |
26.00 |
| Trailing Twelve Months |
| Year End |
202512 |
| Sales |
10,713.37 |
| OPM |
23.28 |
| NP |
2,069.02 |
| NP Var% |
11.80 |
| EPS |
36.91 |
| PE |
36.19 |
|